Strada™ is acting through several potentially different mechanisms of action in the treatment of depression.  These novel mechanisms include mediation of cytokine effects on the CNS which may play a role in changing the pathophysiology of the disease.  Strada™ may also act as an indirect dopaminergic agent, impacting membrane fluidity and reducing neuroinflammation.